# Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function

> **NCT00541814** · PHASE4 · UNKNOWN · sponsor: **University Hospital Birmingham** · enrollment: 90 (estimated)

## Conditions studied

- Chronic Allograft Nephropathy

## Interventions

- **DRUG:** Cyclosporine

## Key facts

- **NCT ID:** NCT00541814
- **Lead sponsor:** University Hospital Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-10
- **Primary completion:** —
- **Final completion:** 2010-02
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2008-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00541814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00541814, "Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00541814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*